These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

429 related items for PubMed ID: 6201411

  • 1. Serum alpha-fetoprotein in the early stage of human hepatocellular carcinoma.
    Chen DS, Sung JL, Sheu JC, Lai MY, How SW, Hsu HC, Lee CS, Wei TC.
    Gastroenterology; 1984 Jun; 86(6):1404-9. PubMed ID: 6201411
    [Abstract] [Full Text] [Related]

  • 2. Serial changes in serum alpha-fetoprotein prior to detection of hepatocellular carcinoma in liver cirrhosis.
    Kuwahara T, Sakai T, Majima Y, Hirai K, Tanikawa K.
    Hepatogastroenterology; 1993 Aug; 40(4):347-51. PubMed ID: 7691701
    [Abstract] [Full Text] [Related]

  • 3. Quantitation of alpha-fetoprotein messenger RNA for early detection of recurrent hepatocellular carcinoma: a prospective pilot study.
    Schmilovitz-Weiss H, Stemmer SM, Liberzon E, Avigad S, Sulkes J, Belinki A, Kazatsker A, Ben-Ari Z.
    Cancer Detect Prev; 2006 Aug; 30(2):204-9. PubMed ID: 16638626
    [Abstract] [Full Text] [Related]

  • 4. Fucosylation index of alpha-fetoprotein, a possible aid in the early recognition of hepatocellular carcinoma in patients with cirrhosis.
    Aoyagi Y, Saitoh A, Suzuki Y, Igarashi K, Oguro M, Yokota T, Mori S, Suda T, Isemura M, Asakura H.
    Hepatology; 1993 Jan; 17(1):50-2. PubMed ID: 7678576
    [Abstract] [Full Text] [Related]

  • 5. Clinical significance of simultaneous determinations of alpha-fetoprotein and des-gamma-carboxy prothrombin in monitoring recurrence in patients with hepatocellular carcinoma.
    Aoyagi Y, Oguro M, Yanagi M, Mita Y, Suda T, Suzuki Y, Hata K, Ichii K, Asakura H.
    Cancer; 1996 May 01; 77(9):1781-6. PubMed ID: 8646674
    [Abstract] [Full Text] [Related]

  • 6. Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein.
    Sato Y, Nakata K, Kato Y, Shima M, Ishii N, Koji T, Taketa K, Endo Y, Nagataki S.
    N Engl J Med; 1993 Jun 24; 328(25):1802-6. PubMed ID: 7684823
    [Abstract] [Full Text] [Related]

  • 7. Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma.
    Oka H, Tamori A, Kuroki T, Kobayashi K, Yamamoto S.
    Hepatology; 1994 Jan 24; 19(1):61-6. PubMed ID: 7506227
    [Abstract] [Full Text] [Related]

  • 8. A clinical study of lectin-reactive alpha-fetoprotein as an early indicator of hepatocellular carcinoma in the follow-up of cirrhotic patients.
    Shiraki K, Takase K, Tameda Y, Hamada M, Kosaka Y, Nakano T.
    Hepatology; 1995 Sep 24; 22(3):802-7. PubMed ID: 7544756
    [Abstract] [Full Text] [Related]

  • 9. Early diagnosis of hepatocellular carcinoma.
    Okazaki N, Yoshino M, Yoshida T, Takayasu K, Moriyama N, Makuuchi M, Yamazaki S, Hasegawa H, Noguchi M, Hirohashi S.
    Hepatogastroenterology; 1990 Oct 24; 37(5):480-3. PubMed ID: 1701411
    [Abstract] [Full Text] [Related]

  • 10. [Correlation between serum alpha-fetoprotein variant levels in patients with hepatocellular carcinoma and the presence of alpha-fetoprotein mRNA in the circulating blood].
    Kang XY, Yin ZF, Qian HH, Wu ZD, Yu ZX, Wu MC.
    Zhonghua Gan Zang Bing Za Zhi; 2003 Jan 24; 11(1):17-9. PubMed ID: 12546734
    [Abstract] [Full Text] [Related]

  • 11. Serum alpha-fetoprotein and hepatocellular carcinoma size.
    Piantino P, Fusaro A, Daziano E.
    J Nucl Med Allied Sci; 1989 Jan 24; 33(3 Suppl):131. PubMed ID: 2480412
    [No Abstract] [Full Text] [Related]

  • 12. Radioimmunoassay of serum IGF-I and IGF-II in patients with chronic liver diseases and hepatocellular carcinoma with or without hypoglycemia.
    Wu JC, Daughaday WH, Lee SD, Hsiao TS, Chou CK, Lin HD, Tsai YT, Chiang BN.
    J Lab Clin Med; 1988 Nov 24; 112(5):589-94. PubMed ID: 2460570
    [Abstract] [Full Text] [Related]

  • 13. Alpha-fetoprotein in the early diagnosis of hepatocellular carcinoma.
    Ballesta AM, Calvet X, Filella X, Bruix J, Bru C, Molina R, Rodes J.
    J Nucl Med Allied Sci; 1989 Nov 24; 33(3 Suppl):39-41. PubMed ID: 2480420
    [Abstract] [Full Text] [Related]

  • 14. Serum alpha-L-fucosidase activity and tumor size in hepatocellular carcinoma.
    Takahashi H, Saibara T, Iwamura S, Tomita A, Maeda T, Onishi S, Yamamoto Y, Enzan H.
    Hepatology; 1994 Jun 24; 19(6):1414-7. PubMed ID: 7514563
    [Abstract] [Full Text] [Related]

  • 15. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
    Durazo FA, Blatt LM, Corey WG, Lin JH, Han S, Saab S, Busuttil RW, Tong MJ.
    J Gastroenterol Hepatol; 2008 Oct 24; 23(10):1541-8. PubMed ID: 18422961
    [Abstract] [Full Text] [Related]

  • 16. [Levels of serum alpha-fetoprotein before and after transcatheter embolization of hepatocellular tumors with Lipiodol].
    Mlinarić B.
    Lijec Vjesn; 2000 Oct 24; 122(1-2):6-8. PubMed ID: 10916349
    [Abstract] [Full Text] [Related]

  • 17. Clinicopathologic features and risk factors for hepatocellular carcinoma: results from a single center in southern Turkey.
    Ozer B, Serin E, Yilmaz U, Gümürdülü Y, Saygili OB, Kayaselçuk F, Boyacioğlu S.
    Turk J Gastroenterol; 2003 Jun 24; 14(2):85-90. PubMed ID: 14614632
    [Abstract] [Full Text] [Related]

  • 18. The humoral immune response to p53 in patients with hepatocellular carcinoma is specific for malignancy and independent of the alpha-fetoprotein status.
    Volkmann M, Müller M, Hofmann WJ, Meyer M, Hagelstein J, Räth U, Kommerell B, Zentgraf H, Galle PR.
    Hepatology; 1993 Sep 24; 18(3):559-65. PubMed ID: 7689531
    [Abstract] [Full Text] [Related]

  • 19. Clinical characteristics among patients with hepatocellular carcinoma according to the serum levels of alpha-fetoprotein and des-y-carboxy prothrombin.
    Dohmen K, Shigematsu H, Irie K, Ishibashi H.
    Hepatogastroenterology; 2003 Sep 24; 50(54):2072-8. PubMed ID: 14696467
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.